Global Molecular Cytogenetics Market 2017-2021

Molecular cytogenetics market growth

According to the molecular cytogenetics industry analysis, the global molecular cytogenetics market will grow at a CAGR of close to 11% during the forecast period. The growing prevalence of cancer and leukemia and the rising need to detect chromosomal aberrations have driven the emergence of FISH and CGH as valuable tools for clinical research and diagnosis.

The increasing usage of FISH and CGH for the diagnosis of several diseases will boost the popularity of molecular cytogenetic techniques in the forthcoming years. FISH detects specific DNA sequences with fluorescently labeled DNA microarray to identify the complex chromosomal rearrangements. This enables the early detection of cancer. The use of CGH is further increased due to the introduction of cross-species array CGH analysis in the identification of cancer genes.

Get A Free Sample

Molecular cytogenetics market trends

The rising popularity of the targeted cancer treatment acts as one of the key trends that will stimulate growth in the molecular cytogenetics market until the end of 2021. Targeted cancer treatment reduces the complexity of treatment by enabling researchers and clinicians to choose the best testing strategy that helps to identify the affected cell from the whole lot of rapidly dividing cells. This results in the popularity of modern cytogenetic testing such as array CGH and FISH-based tests.

Molecular cytogenetics market worth: Competitive landscape and key vendors

The molecular cytogenetics market is characterized by the presence of many local and global vendors. These vendors are increasingly competing against each other based on factors such as service, quality, pricing, and product differentiation. To achieve sustained growth in the cytogenetic testing market, the vendors are also trying to expand their presence across several geographic regions.

Key vendors in the molecular cytogenetics market

• Abbott Laboratories
• Agilent Technologies
• Bio-Rad Laboratories
• Thermo Fisher Scientific

Molecular cytogenetics industry analysis by end-users

• Clinical and research laboratories
• Pharmaceutical and biotechnology companies

The application of molecular cytogenetics is increasing in the clinical and research laboratories due to the rising awareness about preventive screening. Clinicians extensively use FISH and CGH to screen diseases at an early stage to reduce mortality rates. This will boost the adoption of preventing screening and molecular cytogenetics in the research and clinical laboratories for the next four years.

Molecular cytogenetics market worth by geography

• Americas
• APAC
• EMEA

The development of targeted cancer treatments is increasing in the Americas due to the growing prevalence of cancer in the US. Clinicians and researchers are increasingly recommending targeted cancer treatment since it avoids chemotherapy. This, in turn, will drive the growth of the cytogenetic testing market in this region during the estimated period.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global molecular cytogenetics market?
• What are the key market trends impacting the growth of the global molecular cytogenetics market?
• What are the challenges to market growth?
• Who are the key vendors in the global molecular cytogenetics market?
• What are the market opportunities and threats faced by the vendors in the global molecular cytogenetics market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global molecular cytogenetics market?

Technavio also offers customization on reports based on specific client requirement.